Exploring the clinical efficacy and mechanism of high-position colon dialysis combined with Traditional Chinese Medicine retention enema in real-world patients with stage 3-5 chronic kidney disease (non-dialysis) based on the theory of the Gut-Kidney axis.

Deng Y, Zhang L, Chen S, Xu D, Wu W, Shen T, Liu Z, Yang L, Wen A, Hou Y, Shao F

Open source

DOI
10.3389/fphar.2023.1246852
Published
2023
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2023.1246852,
  title = {Exploring the clinical efficacy and mechanism of high-position colon dialysis combined with Traditional Chinese Medicine retention enema in real-world patients with stage 3-5 chronic kidney disease (non-dialysis) based on the theory of the Gut-Kidney axis.},
  author = {Deng Y and Zhang L and Chen S and Xu D and Wu W and Shen T and Liu Z and Yang L and Wen A and Hou Y and Shao F},
  year = {2023},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2023.1246852},
  url = {https://doi.org/10.3389/fphar.2023.1246852}
}

RIS

TY  - JOUR
TI  - Exploring the clinical efficacy and mechanism of high-position colon dialysis combined with Traditional Chinese Medicine retention enema in real-world patients with stage 3-5 chronic kidney disease (non-dialysis) based on the theory of the Gut-Kidney axis.
AU  - Deng Y
AU  - Zhang L
AU  - Chen S
AU  - Xu D
AU  - Wu W
AU  - Shen T
AU  - Liu Z
AU  - Yang L
AU  - Wen A
AU  - Hou Y
AU  - Shao F
PY  - 2023
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2023.1246852
UR  - https://doi.org/10.3389/fphar.2023.1246852
ER  - 

APA

Y, D., L, Z., S, C., D, X., W, W., T, S., Z, L., L, Y., A, W., Y, H., & F, S. (2023). Exploring the clinical efficacy and mechanism of high-position colon dialysis combined with Traditional Chinese Medicine retention enema in real-world patients with stage 3-5 chronic kidney disease (non-dialysis) based on the theory of the Gut-Kidney axis.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2023.1246852

Source records